Inactivated SARS-CoV-2 vaccine dosing schedules and antibody responses in adults aged 60 to 80 years
Older adults get better protection with the right vaccine booster timing
This prospective cohort study of 450 adults aged 60 to 80 years in China examined three inactivated SARS-CoV-2 vaccine dosing schedules. The…
New data shows older adults get the best protection when they receive specific vaccine boosters at the right time.
Omicron linked to multisystem long COVID and GI symptoms in veterans study
Omicron infection raises risk of multisystem long COVID for veterans
This retrospective cohort study of 1,120 veterans at a VA Medical Center found Omicron variants associated with increased multisystem long C…
Omicron variants caused more multisystem long COVID symptoms than earlier strains in a large rural veteran study group.
Multiplex diagnostic test distinguishes long COVID patients from recovered controls with moderate diagnostic accuracy
A New Blood Test Helps Explain Why Long COVID Lasts
This observational cohort study compared 46 recovered controls and 113 long COVID patients using a multiplex diagnostic test. Results showed…
Scientists found a way to group Long COVID patients based on their body's reaction to the virus.
Mechanistic review discusses host-directed therapy for children with Long COVID and secondary bacterial pneumonia.
Could monitoring specific blood markers help prevent long-term lung damage in kids with Long COVID?
This mechanistic review addresses Long COVID, Post-Acute Sequelae of SARS-CoV-2 infection, and secondary bacterial pneumonia in children. Th…
Monitoring blood markers like ferritin and D-dimer could help doctors catch dangerous lung inflammation early in kids with Long COVID before…
Pre-infection symptoms and functional status associated with long COVID risk in 65,464 U.S. adults
Did you know older age and female sex increase long COVID risk?
This retrospective cohort study of 65,464 U.S. adults with a history of COVID-19 enrolled in the All of Us Research Program examined the ris…
Older age, female sex, and lower mental health before infection raise long COVID risk, while having more pre-existing symptoms also increase…
Observational study identifies distinct immunophenotypic signatures in ME/CFS and long COVID compared to healthy controls.
Two Look-Alike Illnesses May Finally Have Separate Fingerprints
This observational study analyzed peripheral blood mononuclear cells from 207 participants with myalgic encephalomyelitis/chronic fatigue sy…
For the first time, scientists can tell two confusing, often-mixed-up illnesses apart by looking at specific immune cells in the blood.
US observational study examines prevalence of self-reported Long COVID in adults
Study examines how many U.S. adults report having experienced Long COVID
An observational study in US adults examined the prevalence of self-reported Long COVID. The study did not report specific prevalence rates,…
A new report describes the prevalence of adults who reported ever experiencing Long COVID, offering a preliminary look at how common the con…
Phase 2 trial of Paxlovid for Long COVID cognitive, autonomic, and exercise symptoms completed.
Can Paxlovid help people with Long COVID? A major trial is underway.
A prospective, multi-center, double-blind, randomized, controlled Phase 2 trial enrolled 964 individuals with PASC to evaluate Paxlovid. The…
A major trial is testing whether Paxlovid can ease Long COVID symptoms like brain fog and severe fatigue in nearly 1,000 people.
Hyperbaric oxygen therapy associated with improved sleep quality in retrospective cohort study
Hyperbaric oxygen therapy linked to improved sleep quality in retrospective study
A retrospective longitudinal cohort study of 395 patients undergoing hyperbaric oxygen therapy for healthy aging, long COVID, or PTSD found …
Patients treated with hyperbaric oxygen therapy for aging, long COVID, or PTSD all reported significantly better sleep quality after complet…